Form 4: Option Care Health CEO Granted 78,876 Restricted Stock Units

Option Care Health's CEO and Director, John Charles Rademacher, was granted 78,876 restricted stock units, vesting over three years.

Summary

• John Charles Rademacher, Chief Executive Officer and Director of Option Care Health, Inc. (OPCH), was granted 78,876 shares of Common Stock in the form of Restricted Stock Units (RSUs).
• The transaction date for this grant was February 18, 2026.
• The acquisition price for these shares was $0, which is typical for RSU grants.
• Following this reported transaction, Mr. Rademacher beneficially owns 831,057 shares of Common Stock.
• The restricted stock units will vest as to one-third of the underlying shares on each of the first, second, and third anniversaries of the grant date.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. It represents a routine executive compensation action that aligns management incentives with shareholder interests, without indicating any immediate operational or financial performance changes.

Positives

• The grant of restricted stock units to the CEO aligns management's long-term interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• This is a standard form of executive compensation, indicating a structured approach to incentivizing leadership.

Future Outlook

The restricted stock units granted to the CEO are scheduled to vest in three equal annual installments on the first, second, and third anniversaries of the February 18, 2026 grant date, providing a future incentive structure.

Industry Context

StockSavvy.ai notes that RSU grants are a common and widely accepted form of executive compensation across various industries, including healthcare services. This practice is designed to align the interests of executives with the long-term performance and shareholder value of the company.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to a Chief Executive Officer is a standard practice in executive compensation packages across the healthcare services industry and broader public markets.
• RSUs are generally favored for their ability to align executive incentives with long-term shareholder value creation, similar to practices observed at comparable companies in the sector.
• No specific comparable companies, projects, or results were mentioned in the filing itself for a direct quantitative comparison.

Stakeholder Impact

• Shareholders: The RSU grant aligns the CEO's financial incentives with the company's stock performance, potentially benefiting shareholders through motivated leadership focused on long-term value creation.

Next Steps

• Vesting of one-third of the granted restricted stock units on the first anniversary of the grant date (February 18, 2027).
• Vesting of one-third of the granted restricted stock units on the second anniversary of the grant date (February 18, 2028).
• Vesting of one-third of the granted restricted stock units on the third anniversary of the grant date (February 18, 2029).

Key Dates

Keywords

Option Care Health, OPCH, John Charles Rademacher, Restricted Stock Units, RSU, Stock Grant, Executive Compensation, Insider Transaction, Form 4